In CVID specifically, a break in central B cell tolerance driving autoantibody production has been described (63) and correlated with underlying genetic etiology in the case of monoallelic TNFRS13B (encoding TACI) mutations (64). The gene discussed is TNFRSF13B; the disease is common variable immunodeficiency.